m.Stock by Mirae AssetOpen Demat Account
m.Stock by Mirae Asset

IPO Asston Pharmaceuticals Ltd

  • Price Range

    -

  • Min. Quantity

    -

  • Closes on

    -

  • Min. investment

    -

Asston Pharmaceuticals Ltd IPO Timeline

Asston Pharmaceuticals Limited was incorporated on 16th April 2019 as 'Asston Pharmaceutical Pvt. Limited' to contract produce pharmaceutical products for export market. Later on 1st April 2024, Company acquired Ferron Lifecare Private Limited, specializing into nutraceuticals business and produced nutraceutical products at their Ambarnath facility. Ferron Lifecare Private Limited, incorporated on 30th January 2020 was promoted by Dr. Ashish Sakalkar and Mr. Sachin Badakh. Finally, 'Asston Pharmaceuticals Private Limited' was converted from a Private Limited into a Public Limited Company in the name of 'Asston Pharmaceuticals Limited' on 29th August 2024 and received FDA approval for its Ambarnath facility on 2nd December 2024 to produce pharmaceutical products.

EventDate
Asston Pharmaceuticals Ltd IPO Opening Date9 July 2025
Asston Pharmaceuticals Ltd IPO Closing Date 11 July 2025
Basis of Allotment14 July 2025
Initiation of Refunds15 July 2025
Credit of Shares to Demat15 July 2025
Asston Pharmaceuticals Ltd IPO Listing Date16 July 2025

Asston Pharmaceuticals Ltd IPO Details

Asston Pharmaceuticals Ltd IPO Date-
Asston Pharmaceuticals Ltd IPO Face Value-
Asston Pharmaceuticals Ltd IPO Price-
Asston Pharmaceuticals Ltd IPO Lot Size-
Issue Size-
Fresh Issue-
Offer for Sale-
Issue Type-
Listing At-
QIB Shares Offered-
Retail Shares Offered-
NII (HNI) Shares Offered-
Company PromotersAshish Narayan Sakalkar, Saili Jayaram More, Sachin Chandrakant Badakh

Asston Pharmaceuticals Ltd IPO Lot Size

The Asston Pharmaceuticals Ltd IPO lot size is Invalid Number shares. A retail-individual investor can apply for up to NaN lots (NaN shares or ₹NaN).

Application LotsSharesAmount
Minimum1--
Maximum---
  • Risks
  • Opportunities
  • Formulation Expertise.
  • Experienced Promoters.
  • Wide range of Products.
  • Strategic Location.
  • Skilled Workforce.
  • Good relationship with contract manufacturers.
  • Quality Assurance.
  • Good relationship with clients in the export market.
  • Competitive Pricing.
  • Asset Light Model.

Company Financials

Asston Pharmaceuticals Ltd Financial Information (Restated)

Period Ended Total AssetsTotal RevenueProfit After Tax
03-202420.2615.841.36
03-202313.697.191.06
03-20229.4910.550.11
Amount in ₹ Crore

Objects of the Issue

The company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:

  • Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit
  • Funding the incremental working capital requirements of our company
  • Repayment and/or prepayment, in part or full, of certain of our outstanding borrowings availed by our company.
  • General corporate purposes

Asston Pharmaceuticals Ltd IPO Promoter Holding

Pre Issue Share Holding29.54%
Post Issue Share Holding21.77%

Asston Pharmaceuticals Ltd IPO Subscription Status (Bidding Detail)

The Asston Pharmaceuticals Ltd IPO is subscribed 0 times on NaN Invalid undefined 05:00:00 PM. The public issue subscribed 0 times in the retail category, 0 times in the QIB category, and 0 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategoryQIBNIIRetailEmployeeTotal
Subscription (times)-----

Asston Pharmaceuticals Ltd IPO Prospectus

Asston Pharmaceuticals Ltd IPO Listing Date

BSE Script -
NSE Symbol-
Listing In-
ISININE0SJX01015
IPO Price₹0
Face Value10

Company Contact Information

Asston Pharmaceuticals Ltd
4th Flr Office No.A-431 BalajiBhavan Plot No.42A Sec-11 CBD,Mumbai-400614
Phone: +91 22 4973 1411/+91 22 4973 1419
Email: info@asstonpharmaceuticals.com
Website: www.asstonpharmaceuticals.com

Asston Pharmaceuticals Ltd IPO Registrar

Phone:+91 11 47581432
Email: ipo@maashitla.com
Website: www.maashitla.com

Asston Pharmaceuticals Ltd IPO Lead Manager(s)

  1. Sobhagya Capital Options Pvt. Ltd.

FAQ

What is the issue size of Asston Pharmaceuticals Ltd IPO?

Asston Pharmaceuticals Ltd IPO, which opens for subscription from to NaN Invalid undefined has an issue size of ₹Invalid Number crore. The issue type is book building issue.

I have pre-applied for Asston Pharmaceuticals Ltd IPO. When will my order get placed?

In case of pre-apply, your IPO order will be placed on the Exchange as soon as the official bidding for TBI Corn Ltd IPO begins. You will receive a UPI request within 24 hours after the bidding period opens.

What are the open and close dates for Asston Pharmaceuticals Ltd IPO?

Asston Pharmaceuticals Ltd IPO Opens for subscription from NaN Invalid undefined to NaN Invalid undefined

What is the lot size and minimum order quantity of the Asston Pharmaceuticals Ltd IPO?

The lot size of Asston Pharmaceuticals Ltd is Invalid Number shares. Retail investors can subscribe to minimum 1 lot and maximum NaN lots. The minimum and maximum application value is ₹NaN and ₹NaN respectively.

What are the allotment dates for the Asston Pharmaceuticals Ltd IPO?

Allotment date for Asston Pharmaceuticals Ltd is 14 July 2025 and refund of application amount (in case allotment is not received) will begin from 15 July 2025. If your allotment goes through, then shares will be credited in your Demat account by 15 July 2025.

Who is the registrar of Asston Pharmaceuticals Ltd IPO?

The registrar for Asston Pharmaceuticals Ltd IPO is Maashitla Securities Pvt Ltd. You can check your IPO allotment status on the registrar's website.

Where is the Asston Pharmaceuticals Ltd IPO getting listed?

The shares of Asston Pharmaceuticals Ltd are proposed to be listed on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE)